Synergy CHC (NASDAQ:SNYR) Earns Buy Rating from Analysts at Ascendiant Capital Markets

Ascendiant Capital Markets initiated coverage on shares of Synergy CHC (NASDAQ:SNYRFree Report) in a research note issued to investors on Monday morning, MarketBeat reports. The firm issued a buy rating and a $5.00 target price on the stock.

Other equities analysts also recently issued research reports about the company. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Synergy CHC in a research report on Monday, December 29th. Wall Street Zen lowered shares of Synergy CHC from a “buy” rating to a “hold” rating in a research note on Saturday, November 8th. Finally, Roth Mkm reduced their price target on shares of Synergy CHC from $10.00 to $7.00 and set a “buy” rating on the stock in a research note on Friday, November 14th. Two investment analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $6.00.

View Our Latest Stock Analysis on SNYR

Synergy CHC Trading Down 3.8%

Shares of NASDAQ:SNYR opened at $1.79 on Monday. Synergy CHC has a 12 month low of $1.30 and a 12 month high of $4.25. The company has a market capitalization of $20.14 million, a price-to-earnings ratio of 6.17 and a beta of 3.48. The firm’s 50-day moving average is $1.86 and its 200 day moving average is $2.38.

Synergy CHC (NASDAQ:SNYRGet Free Report) last announced its earnings results on Thursday, November 13th. The company reported $0.01 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.01. The business had revenue of $8.01 million during the quarter. Synergy CHC had a negative return on equity of 19.51% and a net margin of 7.77%. As a group, equities analysts forecast that Synergy CHC will post 0.36 EPS for the current fiscal year.

Institutional Trading of Synergy CHC

Several institutional investors and hedge funds have recently made changes to their positions in the company. Geode Capital Management LLC purchased a new stake in Synergy CHC in the second quarter worth about $29,000. XTX Topco Ltd bought a new stake in shares of Synergy CHC in the 2nd quarter valued at about $57,000. Sanders Morris Harris LLC lifted its position in shares of Synergy CHC by 5.0% in the 3rd quarter. Sanders Morris Harris LLC now owns 391,702 shares of the company’s stock worth $956,000 after purchasing an additional 18,701 shares during the period. Warberg Asset Management LLC purchased a new stake in shares of Synergy CHC in the 3rd quarter worth approximately $82,000. Finally, Heartland Advisors Inc. bought a new position in shares of Synergy CHC during the third quarter valued at approximately $1,342,000.

Synergy CHC Company Profile

(Get Free Report)

Synergy CHC Corp. engages in the marketing and distribution of branded health and wellness products. The company was founded on December 29, 2010 and is headquartered in Westbrook, ME.

See Also

Receive News & Ratings for Synergy CHC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synergy CHC and related companies with MarketBeat.com's FREE daily email newsletter.